Robert Eckert insider trades

Open-market stock purchases and sales by Robert Eckert, Director at Amgen Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +123%.

Recent trades

DateStockTradeValue
May 19, 2026AMGN Amgen IncBought (not open market)—
May 6, 2026LEVI Levi Strauss & CoBought (not open market)—
May 6, 2026LEVI Levi Strauss & CoBought (not open market)—
May 5, 2026UBER Uber Technologies, IncBought (not open market)—
Apr 22, 2026LEVI Levi Strauss & CoBought (not open market)—
Feb 25, 2026LEVI Levi Strauss & CoBought (not open market)—
Feb 25, 2026LEVI Levi Strauss & CoBought (not open market)—
Nov 4, 2025LEVI Levi Strauss & CoBought (not open market)—
Nov 4, 2025LEVI Levi Strauss & CoBought (not open market)—

Companies traded

  • AMGN Amgen Inc: 1 sale, last May 19, 2026
  • LEVI Levi Strauss & Co: other filings, last May 6, 2026
  • UBER Uber Technologies, Inc: 1 buy, last May 5, 2026
  • MCD McDonalds Corp: 2 sales, last Dec 31, 2022
  • MAT Mattel Inc /de/: 6 sales, last Dec 31, 2012

Get free alerts when Robert Eckert files a new trade →